15 July 2022 -  Xembify is yet another presentation of human immunoglobulin.

Xembify is indicated as replacement therapy in adult and paediatric patients for:

• Primary immunodeficiency diseases
• Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment

Read TGA prescription medicine decision summary